loadpatents
name:-0.01366400718689
name:-0.0025861263275146
name:-0.0014369487762451
LIECHTI; Matthias Emanuel Patent Filings

LIECHTI; Matthias Emanuel

Patent Applications and Registrations

Patent applications and USPTO patent grants for LIECHTI; Matthias Emanuel.The latest application filed is for "using geno- or phenotyping to adjust lsd dosing".

Company Profile
1.1.11
  • LIECHTI; Matthias Emanuel - Oberwil CH
  • LIECHTI; Matthias Emanuel - Oberwill CH
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Using Geno- Or Phenotyping To Adjust Lsd Dosing
App 20220280501 - LIECHTI; Matthias Emanuel ;   et al.
2022-09-08
Effects Of Lysergic Acid Diethylamide (lsd) And Of Lsd Analogs To Assist Psychotherapy For Generalized Anxiety Disorder Or Other Anxiety Not Related To Life-threatening Illness
App 20220273628 - LIECHTI; Matthias Emanuel ;   et al.
2022-09-01
Mescaline Derivatives With Modified Action
App 20220267252 - TRACHSEL; Daniel ;   et al.
2022-08-25
Effects Of Mescaline And Of Mescaline Analogs (scalines) To Assist Psychotherapy
App 20220265582 - LIECHTI; Matthias Emanuel
2022-08-25
MDMA treatment to enhance acute emotional effects profile of LSD, psilocybin or other psychedelics
Grant 11,364,221 - Liechti June 21, 2
2022-06-21
Mdma Prodrugs To Assist Psychotherapy
App 20220151986 - LIECHTI; Matthias Emanuel ;   et al.
2022-05-19
Mdma Treatment To Enhance Acute Emotional Effects Profile Of Lsd, Psilocybin Or Other Psychedelics
App 20220096429 - LIECHTI; Matthias Emanuel
2022-03-31
Intravenous Dmt Administration Method For Dmt-assisted Psychotherapy
App 20220040150 - LIECHTI; Matthias Emanuel
2022-02-10
Mdma Response Prediction
App 20210386704 - LIECHTI; Matthias Emanuel ;   et al.
2021-12-16
Mdma Treatment To Enhance Acute Emotional Effects Profile Of Lsd, Psilocybin, Or Other Psychedelics
App 20210346341 - LIECHTI; Matthias Emanuel
2021-11-11
Lsd Dose Identification
App 20210315884 - LIECHTI; Matthias Emanuel ;   et al.
2021-10-14
Controlling Effects After 5ht2a Agonists Administration
App 20210267977 - LIECHTI; Matthias Emanuel
2021-09-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed